IDXG
INTERPACE BIOSCIENCES, INC.Company Information
- Company Name
- INTERPACE BIOSCIENCES, INC.
- CIK
- CIK0001054102
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- IDXG: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- IDXG
SEC filing data through
Insider Sentiment
- Last purchase
- 2021-05-21
- Last sale
- —
- Shares purchased (TTM)
- 27,215
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 18,929,751
- Shares outstanding
- 4,424,000
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 5 | ||||||
| Accounts Receivable Net Current | 6 | 6 | 6 | 6 | 7 | 9 | 9 | 7 | 6 | 5 | 5 | 5 | ||||||
| Other Assets Current | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Assets Current | 11 | 10 | 10 | 9 | 10 | 12 | 12 | 9 | 10 | 9 | 10 | 11 | ||||||
| Property Plant And Equipment Net | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finite Lived Intangible Assets Net | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Deferred Income Tax Assets Net | 21 | 21 | 21 | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 35 | 33 | 34 | 12 | 12 | 14 | 15 | 14 | 13 | 12 | 13 | 14 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | ||||||
| Employee Related Liabilities Current | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | ||||||
| Other Accrued Liabilities Current | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 9 | 9 | 9 | 2 | 9 | ||||||
| Notes Payable Current | - | - | - | 1 | 2 | 3 | 4 | 6 | 7 | 7 | 5 | - | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 5 | 4 | 5 | 6 | 7 | 9 | 11 | 6 | 7 | 19 | 11 | 12 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | - | - | 1 | 4 | 12 | ||||||
| Other Liabilities Noncurrent | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Liabilities | 11 | 10 | 11 | 12 | 14 | 15 | 17 | 25 | 25 | 27 | 22 | 30 | ||||||
Stockholders Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | 47 | 47 | 47 | 47 | 47 | ||||||
| Common Stock Value | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 235 | 235 | 235 | 235 | 235 | 235 | 235 | 188 | 188 | 188 | 188 | 188 | ||||||
| Retained Earnings Accumulated Deficit | -210 | -210 | -211 | -233 | -234 | -234 | -235 | -244 | -246 | -248 | -242 | -249 | ||||||
| Treasury Stock Value | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | ||||||
| Stockholders Equity | 23 | 23 | 22 | -0 | -1 | -1 | -2 | -51 | -52 | -55 | -56 | -63 | ||||||
| Liabilities And Stockholders Equity | 35 | 33 | 34 | 12 | 12 | 14 | 15 | 14 | 13 | 12 | 13 | 14 | ||||||
| Allowance For Doubtful Accounts Receivable | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | - | 0 | 0 | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 28 | 28 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | ||||||
| Shares Outstanding | 28 | 28 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Treasury Stock Common Shares | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialINTERPACE BIOSCIENCES, INC. (IDXG) — SEC Financial Statements & Analysis
INTERPACE BIOSCIENCES, INC. (IDXG) is a surgical & medical instruments & apparatus company, incorporated in DE. INTERPACE BIOSCIENCES, INC. trades on OTC as: IDXG. INTERPACE BIOSCIENCES, INC. (IDXG)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, On profitability, INTERPACE BIOSCIENCES, INC. posts a gross margin of 63.75%, an operating margin of 11.53%, a net margin of 67.64%, a Return on Equity (ROE) of 221.93%, a Return on Assets (ROA) of 104.29%, and a Return on Invested Capital (ROIC) of 38.16%. Per share, it reports EPS of $0.88, diluted EPS of $0.88, free cash flow per share of $0.15, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -20.48% year-over-year, net income growth of 496.27% year-over-year, and EPS growth of -4.79% year-over-year. On the balance sheet, it maintains a current ratio of 2.22x, a quick ratio of 2.22x, working capital of $6.02M, a debt-to-equity ratio of 0.49x, a debt ratio of 0.33, an interest coverage ratio of 101.63x, free cash flow of $4.10M (TTM), and net debt of $-2.69M. Figures sourced from SEC EDGAR.
- EPS TTM
- $0.88
- ROE TTM
- 221.93%
- ROA TTM
- 104.29%
- Debt To Equity
- 0.49x
- Free Cash Flow TTM
- $4.10M
- Net Revenue TTM Growth 1Y
- -20.48%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is INTERPACE BIOSCIENCES, INC. in?
INTERPACE BIOSCIENCES, INC. (IDXG) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does IDXG trade on?
INTERPACE BIOSCIENCES, INC. (IDXG) trades on the OTC.
Where is INTERPACE BIOSCIENCES, INC. incorporated?
INTERPACE BIOSCIENCES, INC. is incorporated in DE.
When was INTERPACE BIOSCIENCES, INC. (IDXG)'s most recent SEC filing?
INTERPACE BIOSCIENCES, INC. (IDXG)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is IDXG's EPS (earnings per share)?
INTERPACE BIOSCIENCES, INC. (IDXG)'s trailing twelve month EPS is $0.88 as of 2026-06-30.
What is IDXG's ROE (return on equity)?
INTERPACE BIOSCIENCES, INC. (IDXG)'s trailing twelve month Return on Equity (ROE) is 221.93% as of 2026-06-30.
What is IDXG's ROA (return on assets)?
INTERPACE BIOSCIENCES, INC. (IDXG)'s trailing twelve month Return on Assets (ROA) is 104.29% as of 2026-06-30.
What is IDXG's ROIC (return on invested capital)?
INTERPACE BIOSCIENCES, INC. (IDXG)'s trailing twelve month Return on Invested Capital (ROIC) is 38.16% as of 2026-06-30.